塞力医疗股价涨5.89%,广发基金旗下1只基金位居十大流通股东,持有122.36万股浮盈赚取178.64万元

Group 1 - The core viewpoint of the news is that Sely Medical has seen a stock price increase of 5.89%, reaching 26.24 CNY per share, with a total market capitalization of 5.515 billion CNY [1] - Sely Medical, established on February 23, 2004, and listed on October 31, 2016, specializes in medical testing services, in vitro diagnostic product agency, and the research, production, and sales of its own in vitro diagnostic products [1] - The revenue composition of Sely Medical includes 39.91% from IVD business, 38.01% from SPD business, and 22.08% from pure sales [1] Group 2 - From the perspective of the top ten circulating shareholders, a fund under GF Fund ranks among the top shareholders of Sely Medical, with GF Healthcare Stock A (004851) newly entering the top ten in Q3, holding 1.2236 million shares, which is 0.58% of the circulating shares [2] - The estimated floating profit for GF Healthcare Stock A today is approximately 1.7864 million CNY [2] - GF Healthcare Stock A was established on August 10, 2017, with a latest scale of 5.185 billion CNY, and has achieved a year-to-date return of 19.74%, ranking 2756 out of 4216 in its category [2]